دورية أكاديمية

[Induction of hospital indebtedness due to medicine purchases under monopoly conditions: the case of imatinib mesylate].

التفاصيل البيبلوغرافية
العنوان: [Induction of hospital indebtedness due to medicine purchases under monopoly conditions: the case of imatinib mesylate].
عنوان ترانسليتريتد: Indução de endividamento hospitalar na compra de medicamento em situação de monopólio: o caso do mesilato de imatinibe.
المؤلفون: Scopel CT, Chaves GC
المصدر: Cadernos de saude publica [Cad Saude Publica] 2015 Mar; Vol. 31 (3), pp. 575-85.
نوع المنشور: English Abstract; Journal Article
اللغة: Portuguese
بيانات الدورية: Publisher: Escola Nacional De Saúde Pública, Fundação Oswaldo Cruz Country of Publication: Brazil NLM ID: 8901573 Publication Model: Print Cited Medium: Internet ISSN: 1678-4464 (Electronic) Linking ISSN: 0102311X NLM ISO Abbreviation: Cad Saude Publica Subsets: MEDLINE
أسماء مطبوعة: Publication: <2012->: Rio De Janeiro : Escola Nacional De Saúde Pública, Fundação Oswaldo Cruz
Original Publication: Rio de Janeiro : A Escola,
مواضيع طبية MeSH: Drug Costs*, Antineoplastic Agents/*economics , Benzamides/*economics , Hospital Costs/*organization & administration , Hospitals, Public/*economics , Hospitals, University/*economics , Piperazines/*economics , Pyrimidines/*economics, Antineoplastic Agents/therapeutic use ; Benzamides/therapeutic use ; Brazil ; Budgets ; Health Expenditures/trends ; Health Policy/economics ; Humans ; Imatinib Mesylate ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy ; Piperazines/therapeutic use ; Pyrimidines/therapeutic use
مستخلص: Medicine expenditures consume a large share of the health budget, so knowledge on the use of these funds is essential for decision-making in public health and improvement of pharmaceutical care. This study analyzed the indebtedness of a high-complexity university hospital due to increased spending on imatinib mesylate. The descriptive study was based on analysis of documents and records in the Hospital Information System (SIH) from 2002 to 2010. Starting with inclusion of the medicine in the budget, the study mapped strategies by the pharmaceutical industry and government, as well as government responses to reduce the product's price. The systematization and publication of information stored in files and electronic databases can help monitor the results of programs funded by the Brazilian Ministry of Health.
المشرفين على المادة: 0 (Antineoplastic Agents)
0 (Benzamides)
0 (Piperazines)
0 (Pyrimidines)
8A1O1M485B (Imatinib Mesylate)
تواريخ الأحداث: Date Created: 20150411 Date Completed: 20150728 Latest Revision: 20190823
رمز التحديث: 20240628
DOI: 10.1590/0102-311x00080314
PMID: 25859724
قاعدة البيانات: MEDLINE
الوصف
تدمد:1678-4464
DOI:10.1590/0102-311x00080314